Article Archives

A modern boardroom table featuring a sleek white medical inhaler device, a laptop displaying pharmaceutical data charts, and a tablet showing a strategic licensing flow chart for 2026.

Inhalation Drug Licensing in 2026: Why Execution-Ready Assets Are Queitly Winning

For years, inhalation drug licensing has been misunderstood. It wasn’t deprioritized because it failed scientifically. It was deprioritized because the […]

Inhalation Drug Licensing in 2026: Why Execution-Ready Assets Are Queitly Winning Read More »

A modern pharmaceutical laboratory transitioning into a digital interface with glowing blue data streams, security shields, and regulatory text representing FDA CSA and EMA Annex 11 compliance.

Computerized System Validation (CSV) in Pharma: 2025 Updates and Preparing for 2026 Compliance

Article / SEQOVA

Computerized System Validation (CSV) is no longer a static compliance exercise. In 2025, regulators made that clear. Both the EMA

Computerized System Validation (CSV) in Pharma: 2025 Updates and Preparing for 2026 Compliance Read More »

A cartoon illustration set in a biotech facility, showing one robot pointing to an AI machine displaying "+500% VALUE," while another robot labeled "GMP COMPLIANCE" is tangled in red tape behind a "CAUTION: HUMAN VALIDATION REQUIRED" barrier.

AI in Biotech Manufacturing: Where Value Is Real and Where GMP Caution Is Essential

Article / SEQOVA

AI Has Moved From Experiment to Infrastructure In 2025, artificial intelligence (AI) is no longer confined to innovation labs or

AI in Biotech Manufacturing: Where Value Is Real and Where GMP Caution Is Essential Read More »

Business and science collaboration — a handshake between a pharmaceutical executive in a suit and a scientist in a lab coat, symbolizing cross-border partnerships in pharma and biotech.

Building Bridges, Not Just Deals: How SEQOVA Cross-Border Partnerships Are Shaping the Future of Pharma

Article / SEQOVA

In today’s pharma landscape, cross-border collaboration is no longer optional, it’s essential. From biotech startups seeking validation partners to established

Building Bridges, Not Just Deals: How SEQOVA Cross-Border Partnerships Are Shaping the Future of Pharma Read More »

Team of Professionals discussing Mergers and Acquisitions Strategy

Mergers and Acquisitions in the Pharma Industry: A Strategic Imperative

Article / SEQOVA

Pharma M&A trends, key drivers, and top 2023–2024 deals A Structural Pillar of Pharma Strategy: Mergers and Acquisitions Mergers and

Mergers and Acquisitions in the Pharma Industry: A Strategic Imperative Read More »

Pharmacist checking potential drug shortages of stock in the pharmacy

Navigating the Complex Landscape of Drug Shortages: A Global Perspective, Including the Role of Innovative Solutions

Article / SEQOVA

Uncover how drug shortages occur globally, their impacts and the potential solutions. Understanding Drug Shortages Drug shortages have become an

Navigating the Complex Landscape of Drug Shortages: A Global Perspective, Including the Role of Innovative Solutions Read More »

Team Strategy for Registering Medicinal Product in the U.S.

A Comprehensive Guide to Registering a Medicinal Product in the U.S.

Article / SEQOVA

Step-by-step guide to FDA drug registration with timelines, costs, and approval shortcuts Understanding Drug Classification Registering a medicinal product to

A Comprehensive Guide to Registering a Medicinal Product in the U.S. Read More »